BiotechTube
Home/Peptinovo Biopharma/Dr. Jan Van Tornout, MD
DJ

Dr. Jan Van Tornout, MD

Chief Medical Officer

Peptinovo Biopharma

Therapeutic Areas

Oncology

Peptinovo Biopharma Pipeline

DrugIndicationPhase
PNB-281Solid TumorsPreclinical
PALM™ Tubulin DisruptorsSolid TumorsPreclinical
PALM™ Platinum DrugsSolid TumorsPreclinical
PALM™ GemcitabineSolid TumorsPreclinical

Leadership Team at Peptinovo Biopharma

DR
Dr. Ren Homan, PhD
Founder, CSO
DB
Dr. Bill Elliott, PhD
Co-Founder, CTO
ST
Steve Tokarz, MBA
CEO
DW
Dr. Wayne Klohs, PhD
Head of Clinical Design & Oncology Strategy
View full Peptinovo Biopharma profile